Ribocure Pharmaceuticals
Sweden - MölndalPharmaceutical
Focus: Ribocure Pharmaceuticals is a Sweden-based RNA therapeutics company focused on neurology and gene therapy with a Phase 2-stage pipeline of three programs across cardiology, virology, and metabolic disease.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Ribocure Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Ribocure Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
RBD1016
Chronic Hepatitis DClinical Trials (1)
NCT06649266Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis D
Phase 2Help build intelligence for Ribocure Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.